ASCLS eNewsBytes

• Gut bacteria influence brain development September 21, 2021
  Extremely premature infants are at a high risk for brain damage. Researchers have now found possible targets for the early treatment of such damage outside the brain: Bacteria in the gut of premature infants may play a key role. The research team found that the overgrowth of the gastrointestinal tract with the bacterium Klebsiella is […]
• Allergies to mRNA-based COVID-19 vaccines rare, generally mild, study finds September 21, 2021
  Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to researchers.
• Patients with chronic liver diseases have high risk of more severe COVID-19 outcomes September 21, 2021
  Patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis are at risk for having a more severe COVID-19 outcome and patients with cirrhosis have a high mortality rate; however, the pandemic has resulted in less attention on liver transplantation programs and management of advanced liver disease, according to a study published in Annals of Gastroenterology.
• Gene therapy research accelerates for retinal diseases September 21, 2021
  Researchers are expressing optimism that gene therapy can treat a wide range of eye diseases, including some that currently have no treatments. Only one gene therapy has been approved by the Food and Drug Administration so far, and most trials are in early phases, but they are showing promise
• Which diabetes patients are at risk for a hyperglycemic crisis? September 21, 2021
  In a study of over 20,000 adults with type 1 diabetes and another almost 800,000 adults with type 2 diabetes, a slew of sociodemographic and clinical factors were able to identify patients at increased risk for emergency department or hospital visits primarily for the life-threatening diabetic complications of diabetic ketoacidosis or a hyperglycemic hyperosmolar state, […]